| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. | GC & Chief Compliance Officer | Common Stock | 0 | $0 | $9.60 | 08 Jan 2025 | Direct |
| Poseida Therapeutics, Inc. | GC & Chief Compliance Officer | Employee Stock Option (Right to Buy) | 111,700 | 01 Mar 2024 | Direct | ||
| Poseida Therapeutics, Inc. | GC & Chief Compliance Officer | Employee Stock Option (Right to Buy) | 0 | 08 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000141588925001082-leonhardt-harry-j-2025-01-08 | Poseida Therapeutics, Inc. | 08 Jan 2025 | 6 | $0 | 4 | GC & Chief Compliance Officer | 08 Jan 2025, 14:09 |
| /report/000095017024024921-leonhardt-harry-j-2024-03-01 | Poseida Therapeutics, Inc. | 01 Mar 2024 | 3 | -$67,344 | 4 | GC & Chief Compliance Officer | 04 Mar 2024, 17:18 |
| /report/000120919123014906-leonhardt-harry-j-2023-03-01 | Poseida Therapeutics, Inc. | 01 Mar 2023 | 3 | -$23,128 | 4 | GC & Chief Compliance Officer | 02 Mar 2023, 17:26 |
| /report/000120919122014378-leonhardt-harry-j-2022-03-01 | Poseida Therapeutics, Inc. | 01 Mar 2022 | 2 | $0 | 4 | GC & Chief Compliance Officer | 01 Mar 2022, 18:30 |